VitalStone Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$693K Sell
782
-194
-20% -$174K 0.47% 47
2024
Q2
$884K Buy
976
+24
+3% +$19.2K 0.64% 38
2024
Q1
$741K Sell
952
-297
-24% -$211K 0.57% 39
2023
Q4
$728K Buy
1,249
+327
+35% +$191K 0.58% 33
2023
Q3
$551K Buy
922
+795
+626% +$410K 0.47% 37
2023
Q2
$44K Buy
+127
New +$53.3K 0.02% 367
2023
Q1
Sell
-128
Closed -$48K 439
2022
Q4
$48K Buy
+128
New +$45.4K 0.03% 165

Other funds holding LLY

VitalStone Financial's LLY Position: Q3 2024 in Review

VitalStone Financial reduced its Eli Lilly (LLY) stake by 20% in Q3 2024, selling an estimated $174K and leaving 782 shares worth $693K. The position accounts for 0.47% of the portfolio, ranked #47.

VitalStone Financial first reported a position in LLY in Q4 2022 and has held it in 7 quarters since. The position peaked at $884K in Q2 2024. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • VitalStone Financial held 782 shares of Eli Lilly worth $693K as of Q3 2024.
  • VitalStone Financial sold 194 Eli Lilly shares in Q3 2024, an estimated $174K.
  • Eli Lilly made up 0.47% of VitalStone Financial's portfolio in Q3 2024, its #47 holding.
  • VitalStone Financial first reported a position in Eli Lilly in Q4 2022 and has held it in 7 quarters since.
  • VitalStone Financial's Eli Lilly position peaked at $884K in Q2 2024.
  • 3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.